ARV-471, Abemaciclib — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-01 in 2mo
ESTIMATED |
READOUT
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given
Phase 1/2 · Breast Cancer |
PFE PFIZER INC | ARV-471, Abemaciclib |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|